Public Drug Program Formulary Tables – Psoriasis and Psoriatic Arthritis

ProvinceClassGeneric NameDrug NamePsoriasisPsoriatic ArthritisMonographDate of Revision:
AlbertaBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDFJuly 21, 2022
AlbertaSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDFNov 14, 2022
AlbertaBiologics and BiosimilarsAdalimumabHumira®NoNohttps://pdf.hres.ca/dpd_pm/00067414.PDF 27 Jun, 2024
AlbertaBiologics and BiosimilarsAdalimumabHadlima®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00068763.PDFDec 14, 2022
AlbertaBiologics and BiosimilarsAdalimumabHyrimoz®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00073497.PDFDecember 22, 2022
AlbertaBiologics and BiosimilarsAdalimumabIdacio®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00058541.PDFDecember 22, 2022
AlbertaBiologics and BiosimilarsAdalimumabAmgevita®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00067468.PDFOctober 11, 2022
AlbertaBiologics and BiosimilarsAdalimumabHulio®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00071858.PDFOctober 30, 2020
AlbertaBiologics and BiosimilarsAdalimumabAbriladaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00068228.PDFDec 9, 2022
AlbertaBiologics and BiosimilarsAdalimumabSimlandiYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075380.PDFFebruary 3, 2023
AlbertaBiologics and BiosimilarsAdalimumabYuflymaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069429.PDFFebruary 14, 2022
AlbertaSystemic DrugsApremilastOtezla®NoNohttps://pdf.hres.ca/dpd_pm/00057499.PDFJune 7, 2019
AlbertaBiologics and BiosimilarsBimekizumabBimzelxYes – S/ANohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
AlbertaBiologics and BiosimilarsBrodalumabSiliq™NoN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDFMarch 17, 2022
AlbertaSystemic DrugsCelecoxibCelebrexNoNohttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
AlbertaBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – S/Ahttps://pdf.hres.ca/dpd_pm/00053920.PDFJan 18, 2023
AlbertaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDFSeptember 9, 2022
AlbertaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYesN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDFNovember 8, 2022
AlbertaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDFMay 17, 2022
AlbertaSystemic DrugsCyclosporineYes – S/AN/A
AlbertaBiologics and BiosimilarsEtanerceptEnbrel®NoNohttps://pdf.hres.ca/dpd_pm/00060454.PDF27 Jun, 2024
AlbertaBiologics and BiosimilarsEtanerceptErelzi™Yes – S/A Yes – S/Ahttps://pdf.hres.ca/dpd_pm/00069556.PDFFeb 09, 2023
AlbertaBiologics and BiosimilarsEtanerceptBrenzys®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00065129.PDF
AlbertaBiologics and BiosimilarsEtanerceptRymtiYes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00068678.PDF27 Jun, 2024
AlbertaBiologics and BiosimilarsGolimumabSimponi®N/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00074084.PDF
AlbertaBiologics and BiosimilarsGuselkumabTremfya®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
AlbertaPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®Yes - S/AN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF
AlbertaBiologics and BiosimilarsInfliximabRemicade®NoNo https://pdf.hres.ca/dpd_pm/00075118.PDFJanuary 24, 2022
AlbertaBiologics and BiosimilarsInfliximabAvsola®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00065940.PDFJanuary 5, 2023
AlbertaBiologics and BiosimilarsInfliximabInflectra®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00057004.PDFFebruary 25, 2020
British ColumbiaBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDFApril 4, 2016
British ColumbiaSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDFMay 12, 2022
British ColumbiaBiologics and BiosimilarsAdalimumabHumira®No – S/A requests for psoriasis patients who are unable to transition to biosimilar could be considered on an exceptional case-by-case basis.  No – S/A requests for psoriatic arthritis patients who are unable to transition to biosimilar could be considered on an exceptional case-by-case basis.  https://pdf.hres.ca/dpd_pm/00067414.PDFJune 17, 2022
British ColumbiaBiologics and BiosimilarsAdalimumabHadlima®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00068763.PDFApril 13, 2021
British ColumbiaBiologics and BiosimilarsAdalimumabHyrimoz®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00073497.PDFJune 29, 2015
British ColumbiaBiologics and BiosimilarsAdalimumabIdacio®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00058541.PDFDecember 13, 2021
British ColumbiaBiologics and BiosimilarsAdalimumabAmgevita®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00067468.PDFOctober 17, 2017
British ColumbiaBiologics and BiosimilarsAdalimumabHulio®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00071858.PDFAugust 10, 2018
British ColumbiaBiologics and BiosimilarsAdalimumabAbriladaYes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
British ColumbiaBiologics and BiosimilarsAdalimumabSimlandiYes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00075380.PDF27 Jun, 2024
British ColumbiaBiologics and BiosimilarsAdalimumabYuflymaYes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00069429.PDF27 Jun, 2024
British ColumbiaSystemic DrugsApremilastOtezla®NoNohttps://pdf.hres.ca/dpd_pm/00057499.PDF
British ColumbiaBiologics and BiosimilarsBimekizumabBimzelxYes - S/ANohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
British ColumbiaBiologics and BiosimilarsBrodalumabSiliq™NoN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
British ColumbiaSystemic DrugsCelecoxibCelebrexNoYes – S/Ahttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
British ColumbiaBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes - S/Ahttps://pdf.hres.ca/dpd_pm/00053920.PDFAug 02, 2022
British ColumbiaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
British ColumbiaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentNoN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
British ColumbiaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamNoN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
British ColumbiaSystemic DrugsCyclosporineYes – S/AN/A
British ColumbiaBiologics and BiosimilarsetanerceptEnbrel®No – S/A requests for psoriasis patients who are unable to transition to biosimilar could be considered on an exceptional case-by-case basis.  No – S/A requests for psoriatic arthritis patients who are unable to transition to biosimilar could be considered on an exceptional case-by-case basis.  https://pdf.hres.ca/dpd_pm/00060454.PDF
British ColumbiaBiologics and BiosimilarsEtanerceptErelzi™Yes - S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069556.PDF
British ColumbiaBiologics and BiosimilarsEtanerceptBrenzys®Yes - S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00065129.PDF
British ColumbiaBiologics and BiosimilarsGolimumabSimponi®N/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00074084.PDF
British ColumbiaBiologics and BiosimilarsGuselkumabTremfya®NoNohttps://pdf.hres.ca/dpd_pm/00075605.PDF
British ColumbiaPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®NoN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF
British ColumbiaBiologics and BiosimilarsInfliximabRemicade®NoNo https://pdf.hres.ca/dpd_pm/00075118.PDF
British ColumbiaBiologics and BiosimilarsInfliximabAvsola®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00065940.PDF
British ColumbiaBiologics and BiosimilarsInfliximabInflectra®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00057004.PDF
ManitobaBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
ManitobaSystemic DrugsAcitretinSoriatane®, Mint-Acitretin, Taro-AcitretinYesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
ManitobaBiologics and BiosimilarsAdalimumabHumira®Yes - EDS. Hadlima, Hyrimoz, Idacio, Amgevita or Idacio will be the preferred adalimumab option for all adalimumab-naïve patients prescribed an adalimumab product for psoriasis.Yes - EDS. Hadlima, Hyrimoz, Idacio, Amgevita or Idacio will be the preferred adalimumab option for all adalimumab-naïve patients prescribed an adalimumab product for psoriatic arthritis.https://pdf.hres.ca/dpd_pm/00067414.PDF
ManitobaBiologics and BiosimilarsAdalimumabHadlima®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00068763.PDF
ManitobaBiologics and BiosimilarsAdalimumabHyrimoz®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00073497.PDF
ManitobaBiologics and BiosimilarsAdalimumabIdacio®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00058541.PDF
ManitobaBiologics and BiosimilarsAdalimumabAmgevita®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00067468.PDF
ManitobaBiologics and BiosimilarsAdalimumabHulio®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00071858.PDF
ManitobaBiologics and BiosimilarsAdalimumabAbriladaYes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
ManitobaBiologics and BiosimilarsAdalimumabSimlandiYes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00075380.PDF27 Jun, 2024
ManitobaBiologics and BiosimilarsAdalimumabYuflymaYes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00069429.PDF27 Jun, 2024
ManitobaSystemic DrugsApremilastOtezla®NoNohttps://pdf.hres.ca/dpd_pm/00057499.PDF
ManitobaBiologics and BiosimilarsBimekizumabBimzelxYes - EDSNohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
ManitobaSystemic DrugsCelecoxibCelebrex, CelecoxibYesYeshttps://pdf.hres.ca/dpd_pm/00041466.PDF
ManitobaBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – EDShttps://pdf.hres.ca/dpd_pm/00053920.PDF
ManitobaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF27 Jun, 2024
ManitobaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYesN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF27 Jun, 2024
ManitobaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
ManitobaSystemic DrugsCyclosporineRequires EDS, delete this row?YesN/A27 Jun, 2024
ManitobaSystemic DrugsCyclosporineNeoral, Cyclosporine(Strides), Sandoz CyclosporineYes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00069722.PDF
ManitobaBiologics and BiosimilarsEtanerceptEnbrel®Yes – EDS. Erelzi or Brenzys will be the preferred etanercept option for all etanercept-naïve patients prescribed an etanercept product for psoriasis.Yes – EDS. Erelzi or Brenzys will be the preferred etanercept option for all etanercept-naïve patients prescribed an etanercept product for psoriatic arthritis.https://pdf.hres.ca/dpd_pm/00060454.PDF
ManitobaBiologics and BiosimilarsEtanerceptErelzi™Yes – EDS  Yes – EDShttps://pdf.hres.ca/dpd_pm/00069556.PDFDecember 8, 2015
ManitobaBiologics and BiosimilarsEtanerceptBrenzys®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00065129.PDF
ManitobaBiologics and BiosimilarsGolimumabSimponi®N/AYes – EDShttps://pdf.hres.ca/dpd_pm/00074084.PDF
ManitobaBiologics and BiosimilarsGuselkumabTremfya®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
ManitobaPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®YesN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF
ManitobaBiologics and BiosimilarsInfliximabRemicade®Yes – EDS. Inflectra, Renflexis or Avsola will be the preferred infliximab option for all infliximab-naïve patients prescribed an infliximab product.Yes – EDS. Inflectra, Renflexis or Avsola will be the preferred infliximab option for all infliximab-naïve patients prescribed an infliximab product.https://pdf.hres.ca/dpd_pm/00075118.PDF
ManitobaBiologics and BiosimilarsInfliximabAvsola®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00065940.PDF
ManitobaBiologics and BiosimilarsInfliximabInflectra®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00057004.PDF
New BrunswickBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
New BrunswickSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
New BrunswickBiologics and BiosimilarsAdalimumabHumira®NoNohttps://pdf.hres.ca/dpd_pm/00067414.PDF27 Jun, 2024
New BrunswickBiologics and BiosimilarsAdalimumabHadlima®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00068763.PDF
New BrunswickBiologics and BiosimilarsAdalimumabHyrimoz®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00073497.PDF
New BrunswickBiologics and BiosimilarsAdalimumabIdacio®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00058541.PDF
New BrunswickBiologics and BiosimilarsAdalimumabAmgevita®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00067468.PDF
New BrunswickBiologics and BiosimilarsAdalimumabHulio®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00071858.PDF
New BrunswickBiologics and BiosimilarsAdalimumabAbriladaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00068228.PDF
New BrunswickBiologics and BiosimilarsAdalimumabSimlandiYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075380.PDF
New BrunswickBiologics and BiosimilarsAdalimumabYuflymaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069429.PDF27 Jun, 2024
New BrunswickSystemic DrugsApremilastOtezla®NoNohttps://pdf.hres.ca/dpd_pm/00057499.PDF
New BrunswickBiologics and BiosimilarsBimekizumabBimzelxYes – S/ANohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
New BrunswickBiologics and BiosimilarsBrodalumabSiliq™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
New BrunswickSystemic DrugsCelecoxibCelebrexN/AYeshttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
New BrunswickBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – S/Ahttps://pdf.hres.ca/dpd_pm/00053920.PDF
New BrunswickPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
New BrunswickPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYesN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
New BrunswickPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
New BrunswickSystemic DrugsCyclosporineYesN/A
New BrunswickBiologics and BiosimilarsEtanerceptEnbrel®NoNohttps://pdf.hres.ca/dpd_pm/00060454.PDF27 Jun, 2024
New BrunswickBiologics and BiosimilarsEtanerceptErelzi™Yes – S/A Yes – S/Ahttps://pdf.hres.ca/dpd_pm/00069556.PDF
New BrunswickBiologics and BiosimilarsEtanerceptBrenzys®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00065129.PDF
New BrunswickBiologics and BiosimilarsEtanerceptRymtiYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00068678.PDF27 Jun, 2024
New BrunswickBiologics and BiosimilarsGolimumabSimponi®N/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00074084.PDF
New BrunswickBiologics and BiosimilarsGuselkumabTremfya®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
New BrunswickPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®YesN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF
New BrunswickBiologics and BiosimilarsInfliximabRemicade®NoNohttps://pdf.hres.ca/dpd_pm/00075118.PDF27 Jun, 2024
New BrunswickBiologics and BiosimilarsInfliximabAvsola®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00065940.PDF
New BrunswickBiologics and BiosimilarsInfliximabInflectra®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00057004.PDF
Newfoundland and LabradorBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
Newfoundland and LabradorSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
Newfoundland and LabradorBiologics and BiosimilarsAdalimumabHumira®Yes - S/A All SA requests for coverage of adalimumab for adalimumab- naïve patients will be assessed for the biosimilars of adalimumab only. Patients whose initial Special Authority was received before April 17, 2021 will be eligible for coverage of Humira.Yes - S/A All SA requests for coverage of adalimumab for adalimumab- naïve patients will be assessed for the biosimilars of adalimumab only. Patients whose initial Special Authority was received before April 17, 2021 will be eligible for coverage of Humira.https://pdf.hres.ca/dpd_pm/00067414.PDF
Newfoundland and LabradorBiologics and BiosimilarsAdalimumabHadlima®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00068763.PDF
Newfoundland and LabradorBiologics and BiosimilarsAdalimumabHyrimoz®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00073497.PDF
Newfoundland and LabradorBiologics and BiosimilarsAdalimumabIdacio®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00058541.PDF
Newfoundland and LabradorBiologics and BiosimilarsAdalimumabAmgevita®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00067468.PDF
Newfoundland and LabradorBiologics and BiosimilarsAdalimumabHulio®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00071858.PDF
Newfoundland and LabradorBiologics and BiosimilarsAdalimumabAbriladaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00068228.PDF
Newfoundland and LabradorBiologics and BiosimilarsAdalimumabSimlandiYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075380.PDF
Newfoundland and LabradorBiologics and BiosimilarsAdalimumabYuflymaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069429.PDF
Newfoundland and LabradorSystemic DrugsApremilastOtezla®NoNohttps://pdf.hres.ca/dpd_pm/00057499.PDF
Newfoundland and LabradorBiologics and BiosimilarsBimekizumabBimzelxYes – S/ANohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
Newfoundland and LabradorBiologics and BiosimilarsBrodalumabSiliq™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
Newfoundland and LabradorSystemic DrugsCelecoxibN/AYes
Newfoundland and LabradorBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – S/Ahttps://pdf.hres.ca/dpd_pm/00053920.PDFSeptember 12, 2019
Newfoundland and LabradorPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
Newfoundland and LabradorPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentNoN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
Newfoundland and LabradorPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
Newfoundland and LabradorSystemic DrugsCyclosporineYesN/A
Newfoundland and LabradorBiologics and BiosimilarsEtanerceptEnbrel®NoNohttps://pdf.hres.ca/dpd_pm/00060454.PDF
Newfoundland and LabradorBiologics and BiosimilarsEtanerceptErelzi™Yes – S/A Yes – S/Ahttps://pdf.hres.ca/dpd_pm/00069556.PDF
Newfoundland and LabradorBiologics and BiosimilarsEtanerceptBrenzys®Yes – S/A Yes – S/A https://pdf.hres.ca/dpd_pm/00065129.PDF27 Jun, 2024
Newfoundland and LabradorBiologics and BiosimilarsGolimumabSimponi®N/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00074084.PDF
Newfoundland and LabradorBiologics and BiosimilarsGuselkumabTremfya®Yes – S/A Yes – S/A https://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
Newfoundland and LabradorPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®Yes – S/A N/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF27 Jun, 2024
Newfoundland and LabradorBiologics and BiosimilarsInfliximabRemicade®Yes – S/A; Inflectra or Renflexis are the preferred infliximab therapy for treatment naïve patients (coverage will only be considered for Remicade in patients stabilized prior to June 1, 2016). Nohttps://pdf.hres.ca/dpd_pm/00075118.PDF
Newfoundland and LabradorBiologics and BiosimilarsInfliximabAvsola®Yes - S/AYes - SAhttps://pdf.hres.ca/dpd_pm/00065940.PDF
Newfoundland and LabradorBiologics and BiosimilarsInfliximabInflectra®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00057004.PDF
NIHBBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
NIHBSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
NIHBBiologics and BiosimilarsAdalimumabHumira®Yes- only for clients who received approval for Humira before June 11, 2021Yes- only for clients who received approval for Humira before June 11, 2021https://pdf.hres.ca/dpd_pm/00067414.PDF
NIHBBiologics and BiosimilarsAdalimumabHadlima®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068763.PDF
NIHBBiologics and BiosimilarsAdalimumabHyrimoz®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00073497.PDF
NIHBBiologics and BiosimilarsAdalimumabIdacio®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00058541.PDF
NIHBBiologics and BiosimilarsAdalimumabAmgevita®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00067468.PDF
NIHBBiologics and BiosimilarsAdalimumabHulio®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00071858.PDF
NIHBBiologics and BiosimilarsAdalimumabAbriladaYes – L/UYes – S/Ahttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
NIHBBiologics and BiosimilarsAdalimumabSimlandiYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00075380.PDF
NIHBBiologics and BiosimilarsAdalimumabYuflymaYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00069429.PDF
NIHBSystemic DrugsApremilastOtezla®YesNo https://pdf.hres.ca/dpd_pm/00057499.PDF27 Jun, 2024
NIHBBiologics and BiosimilarsBimekizumabBimzelxNoNohttps://pdf.hres.ca/dpd_pm/00074908.PDF
NIHBBiologics and BiosimilarsBrodalumabSiliq™Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
NIHBSystemic DrugsCelecoxibCelebrexN/AYeshttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
NIHBBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – L/Uhttps://pdf.hres.ca/dpd_pm/00053920.PDF
NIHBPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
NIHBPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYesN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
NIHBPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
NIHBSystemic DrugsCyclosporineCyclosporineYesYes
NIHBBiologics and BiosimilarsEtanerceptEnbrel®NoYes- Only for clients who received approval for Enbrel before October 2, 2017https://pdf.hres.ca/dpd_pm/00060454.PDF
NIHBBiologics and BiosimilarsEtanerceptErelzi™NoYes- L/Uhttps://pdf.hres.ca/dpd_pm/00069556.PDF
NIHBBiologics and BiosimilarsEtanerceptBrenzys®NoYes - L/Uhttps://pdf.hres.ca/dpd_pm/00065129.PDF
NIHBBiologics and BiosimilarsEtanerceptRymtiNoYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068678.PDF27 Jun, 2024
NIHBBiologics and BiosimilarsGolimumabSimponi®N/AYes – L/Uhttps://pdf.hres.ca/dpd_pm/00074084.PDF
NIHBBiologics and BiosimilarsGuselkumabTremfya®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
NIHBPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®YesN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF
NIHBBiologics and BiosimilarsInfliximabRemicade®NoNohttps://pdf.hres.ca/dpd_pm/00075118.PDF
NIHBBiologics and BiosimilarsInfliximabAvsola®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00065940.PDF
NIHBBiologics and BiosimilarsInfliximabInflectra®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00057004.PDF
Northwest TerritoriesBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
Northwest TerritoriesSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
Northwest TerritoriesBiologics and BiosimilarsAdalimumabHumira®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00067414.PDF
Northwest TerritoriesBiologics and BiosimilarsAdalimumabHadlima®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068763.PDF
Northwest TerritoriesBiologics and BiosimilarsAdalimumabHyrimoz®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00073497.PDF
Northwest TerritoriesBiologics and BiosimilarsAdalimumabIdacio®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00058541.PDF
Northwest TerritoriesBiologics and BiosimilarsAdalimumabAmgevita®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00067468.PDF
Northwest TerritoriesBiologics and BiosimilarsAdalimumabHulio®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00071858.PDF
Northwest TerritoriesBiologics and BiosimilarsAdalimumabAbriladaYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
Northwest TerritoriesBiologics and BiosimilarsAdalimumabSimlandiYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00075380.PDF
Northwest TerritoriesBiologics and BiosimilarsAdalimumabYuflymaYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00069429.PDF
Northwest TerritoriesSystemic DrugsApremilastOtezla®Yes - L/UNohttps://pdf.hres.ca/dpd_pm/00057499.PDF27 Jun, 2024
Northwest TerritoriesBiologics and BiosimilarsBimekizumabBimzelxNoNohttps://pdf.hres.ca/dpd_pm/00074908.PDF
Northwest TerritoriesBiologics and BiosimilarsBrodalumabSiliq™Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
Northwest TerritoriesSystemic DrugsCelecoxibCelebrexN/AYeshttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
Northwest TerritoriesBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – L/Uhttps://pdf.hres.ca/dpd_pm/00053920.PDF
Northwest TerritoriesPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
Northwest TerritoriesPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYesN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
Northwest TerritoriesPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
Northwest TerritoriesSystemic DrugsCyclosporineYesYes
Northwest TerritoriesBiologics and BiosimilarsEtanerceptEnbrel®NoYes – L/Uhttps://pdf.hres.ca/dpd_pm/00060454.PDF
Northwest TerritoriesBiologics and BiosimilarsEtanerceptErelzi™Yes- L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00069556.PDF
Northwest TerritoriesBiologics and BiosimilarsEtanerceptBrenzys®NoYes - L/Uhttps://pdf.hres.ca/dpd_pm/00065129.PDF
Northwest TerritoriesBiologics and BiosimilarsEtanerceptRymtiNoYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068678.PDF27 Jun, 2024
Northwest TerritoriesBiologics and BiosimilarsGolimumabSimponi®N/AYes – L/Uhttps://pdf.hres.ca/dpd_pm/00074084.PDF
Northwest TerritoriesBiologics and BiosimilarsGuselkumabTremfya®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
Northwest TerritoriesPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®YesN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF27 Jun, 2024
Northwest TerritoriesBiologics and BiosimilarsInfliximabRemicade®NoNohttps://pdf.hres.ca/dpd_pm/00075118.PDF
Northwest TerritoriesBiologics and BiosimilarsInfliximabAvsola®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00065940.PDF
Northwest TerritoriesBiologics and BiosimilarsInfliximabInflectra®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00057004.PDF
Nova ScotiaBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
Nova ScotiaSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
Nova ScotiaBiologics and BiosimilarsAdalimumabHumira®Yes- only for clients who received approval for Humira before December 15, 2021Yes- only for clients who received approval for Humira before December 15, 2021https://pdf.hres.ca/dpd_pm/00067414.PDF
Nova ScotiaBiologics and BiosimilarsAdalimumabHadlima®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00068763.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsAdalimumabHyrimoz®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00073497.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsAdalimumabIdacio®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00058541.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsAdalimumabAmgevita®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00067468.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsAdalimumabHulio®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00071858.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsAdalimumabAbriladaYes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsAdalimumabSimlandiYes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00075380.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsAdalimumabYuflymaYes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00069429.PDF27 Jun, 2024
Nova ScotiaSystemic DrugsApremilastOtezla®YesYeshttps://pdf.hres.ca/dpd_pm/00057499.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsBimekizumabBimzelxYes – EDSNohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsBrodalumabSiliq™Yes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
Nova ScotiaSystemic DrugsCelecoxibCelebrexN/ANohttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – EDShttps://pdf.hres.ca/dpd_pm/00053920.PDF
Nova ScotiaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
Nova ScotiaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentNoN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
Nova ScotiaPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
Nova ScotiaSystemic DrugsCyclosporineYesN/A
Nova ScotiaBiologics and BiosimilarsEtanerceptEnbrel®Yes – EDS; for etanercept-naïve patients whose etanercept therapy is initiated after Nov 1, 2017, a biosimilar will be the product that is approved.  Yes – EDS; for etanercept-naïve patients whose etanercept therapy is initiated after Nov 1, 2017, a biosimilar will be the product that is approved.  https://pdf.hres.ca/dpd_pm/00060454.PDF
Nova ScotiaBiologics and BiosimilarsEtanerceptErelzi™NoYes – EDShttps://pdf.hres.ca/dpd_pm/00069556.PDF
Nova ScotiaBiologics and BiosimilarsEtanerceptBrenzys®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00065129.PDF
Nova ScotiaBiologics and BiosimilarsEtanerceptRymtiYes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00068678.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsGolimumabSimponi®NoYes – EDShttps://pdf.hres.ca/dpd_pm/00074084.PDF
Nova ScotiaBiologics and BiosimilarsGuselkumabTremfya®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
Nova ScotiaPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®NoN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF
Nova ScotiaBiologics and BiosimilarsInfliximabRemicade®Yes – S/A. For infliximab naïve patients whose infliximab therapy is initiated after June 1, 2016, an infliximab biosimilar will be the product approved. Yes – S/A. For infliximab naïve patients whose infliximab therapy is initiated after June 1, 2016, an infliximab biosimilar will be the product approved. https://pdf.hres.ca/dpd_pm/00075118.PDF
Nova ScotiaBiologics and BiosimilarsInfliximabAvsola®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00065940.PDF27 Jun, 2024
Nova ScotiaBiologics and BiosimilarsInfliximabInflectra®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00057004.PDF
NunavutBiologics and BiosimilarsAdalimumabAbriladaYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
NunavutBiologics and BiosimilarsAdalimumabAmgevita®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00067468.PDF
NunavutSystemic DrugsLeflunomideArava®N/AYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
NunavutBiologics and BiosimilarsInfliximabAvsola®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00065940.PDF
NunavutBiologics and BiosimilarsBimekizumabBimzelxNoNohttps://pdf.hres.ca/dpd_pm/00074908.PDF
NunavutBiologics and BiosimilarsEtanerceptBrenzys®NoYes - L/Uhttps://pdf.hres.ca/dpd_pm/00065129.PDF
NunavutPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
NunavutPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®NoN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF27 Jun, 2024
NunavutSystemic DrugsCelecoxibCelebrexN/AYeshttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
NunavutBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – L/Uhttps://pdf.hres.ca/dpd_pm/00053920.PDF
NunavutBiologics and BiosimilarsSecukinumabCosentyx®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00075631.PDF
NunavutPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
NunavutPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYesN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
NunavutPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®YesN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF27 Jun, 2024
NunavutBiologics and BiosimilarsEtanerceptEnbrel®NoYes – L/Uhttps://pdf.hres.ca/dpd_pm/00060454.PDF
NunavutPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
NunavutBiologics and BiosimilarsEtanerceptErelzi™Yes- L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00069556.PDF
NunavutBiologics and BiosimilarsAdalimumabHadlima®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068763.PDF
NunavutBiologics and BiosimilarsAdalimumabHulio®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00071858.PDF
NunavutBiologics and BiosimilarsAdalimumabHumira®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00067414.PDF
NunavutBiologics and BiosimilarsAdalimumabHyrimoz®Yes - L/UYes - L/U
NunavutBiologics and BiosimilarsAdalimumabIdacio®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00058541.PDF
NunavutBiologics and BiosimilarsTildrakizumabIlumya™NoN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
NunavutBiologics and BiosimilarsInfliximabInflectra®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00057004.PDF
NunavutBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
NunavutBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
NunavutSystemic DrugsApremilastOtezla®YesNohttps://pdf.hres.ca/dpd_pm/00057499.PDF27 Jun, 2024
NunavutBiologics and BiosimilarsInfliximabRemicade®NoNohttps://pdf.hres.ca/dpd_pm/00075118.PDF
NunavutBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
NunavutBiologics and BiosimilarsInfliximabRenflexis®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00072737.PDF
OntarioBiologics and BiosimilarsAbataceptOrencia®N/ANo. EAP may cover in specific clinical circumstances. https://pdf.hres.ca/dpd_pm/00070861.PDF
OntarioSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
OntarioBiologics and BiosimilarsAdalimumabAbriladaYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
OntarioBiologics and BiosimilarsAdalimumabAmgevita®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00067468.PDFMarch 13, 2015
OntarioBiologics and BiosimilarsAdalimumabHadlima®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068763.PDF
OntarioBiologics and BiosimilarsAdalimumabHulio®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00071858.PDF
OntarioBiologics and BiosimilarsAdalimumabHumira®Yes - EAPYes - EAPhttps://pdf.hres.ca/dpd_pm/00067414.PDF27 Jun, 2024
OntarioBiologics and BiosimilarsAdalimumabHyrimoz®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00073497.PDF
OntarioBiologics and BiosimilarsAdalimumabIdacio®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00058541.PDF
OntarioBiologics and BiosimilarsAdalimumabSimlandiYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00075380.PDF
OntarioBiologics and BiosimilarsAdalimumabYuflymaYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00069429.PDF
OntarioSystemic DrugsApremilastOtezla®YesYeshttps://pdf.hres.ca/dpd_pm/00057499.PDF27 Jun, 2024
OntarioBiologics and BiosimilarsBimekizumabBimzelxYes - L/UNohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
OntarioBiologics and BiosimilarsBrodalumabSiliq™Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
OntarioSystemic DrugsCelecoxibCelebrexN/ANohttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
OntarioBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – EAPhttps://pdf.hres.ca/dpd_pm/00053920.PDF
OntarioPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYes – in specific clinical situationsN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
OntarioPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYes – in specific clinical situationsN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
OntarioPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYes – in specific clinical situationsN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
OntarioSystemic DrugsCyclosporineYesN/A
OntarioBiologics and BiosimilarsEtanerceptBrenzys®Yes – L/U Yes – L/Uhttps://pdf.hres.ca/dpd_pm/00065129.PDF
OntarioBiologics and BiosimilarsEtanerceptEnbrel®Yes - EAPYes - EAPhttps://pdf.hres.ca/dpd_pm/00060454.PDF27 Jun, 2024
OntarioBiologics and BiosimilarsEtanerceptErelzi™Yes – L/U Yes – L/Uhttps://pdf.hres.ca/dpd_pm/00069556.PDF
OntarioBiologics and BiosimilarsEtanerceptRymtiYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068678.PDF27 Jun, 2024
OntarioBiologics and BiosimilarsGolimumabSimponi®N/AYes - EAPhttps://pdf.hres.ca/dpd_pm/00074084.PDF
OntarioBiologics and BiosimilarsGuselkumabTremfya®Yes - L/UYes - EAPhttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
OntarioPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®YesN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF27 Jun, 2024
OntarioBiologics and BiosimilarsInfliximabAvsola®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00065940.PDF
OntarioBiologics and BiosimilarsInfliximabInflectra®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00057004.PDF
OntarioBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
Prince Edward IslandBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
27 June, 2024Systemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF27 Jun, 2024
Prince Edward IslandBiologics and BiosimilarsAdalimumabHumira®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00067414.PDF
Prince Edward IslandBiologics and BiosimilarsAdalimumabHadlima®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00068763.PDF
Prince Edward IslandBiologics and BiosimilarsAdalimumabHyrimoz®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073497.PDF
Prince Edward IslandBiologics and BiosimilarsAdalimumabIdacio®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00058541.PDF
Prince Edward IslandBiologics and BiosimilarsAdalimumabAmgevita®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00067468.PDF
Prince Edward IslandBiologics and BiosimilarsAdalimumabHulio®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00071858.PDF
Prince Edward IslandBiologics and BiosimilarsAdalimumabAbriladaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
Prince Edward IslandBiologics and BiosimilarsAdalimumabSimlandiYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075380.PDF27 Jun, 2024
Prince Edward IslandBiologics and BiosimilarsAdalimumabYuflymaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069429.PDF27 Jun, 2024
Prince Edward IslandSystemic DrugsApremilastOtezla®NoNohttps://pdf.hres.ca/dpd_pm/00057499.PDF
Prince Edward IslandBiologics and BiosimilarsBimekizumabBimzelxYes – S/ANohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
Prince Edward IslandBiologics and BiosimilarsBrodalumabSiliq™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
Prince Edward IslandSystemic DrugsCelecoxibN/AYes
Prince Edward IslandBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – S/Ahttps://pdf.hres.ca/dpd_pm/00053920.PDF
Prince Edward IslandPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
Prince Edward IslandPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYesN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF27 Jun, 2024
Prince Edward IslandPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
Prince Edward IslandSystemic DrugsCyclosporineYesN/A
Prince Edward IslandBiologics and BiosimilarsEtanerceptEnbrel®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00060454.PDF
Prince Edward IslandBiologics and BiosimilarsEtanerceptErelzi™Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069556.PDF27 Jun, 2024
Prince Edward IslandBiologics and BiosimilarsEtanerceptBrenzys®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00065129.PDF27 Jun, 2024
Prince Edward IslandBiologics and BiosimilarsGolimumabSimponi®NoYes – S/Ahttps://pdf.hres.ca/dpd_pm/00074084.PDF
Prince Edward IslandBiologics and BiosimilarsGuselkumabTremfya®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
Prince Edward IslandPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®NoN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF
Prince Edward IslandBiologics and BiosimilarsInfliximabRemicade®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075118.PDF
Prince Edward IslandBiologics and BiosimilarsInfliximabAvsola®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00065940.PDF27 Jun, 2024
Prince Edward IslandBiologics and BiosimilarsInfliximabInflectra®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00057004.PDF
QuebecBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
QuebecSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
QuebecBiologics and BiosimilarsAdalimumabHumira®Yes - S/A. If treatment began before August 19, 2020.Yes - S/A. If treatment began before August 19, 2020.https://pdf.hres.ca/dpd_pm/00067414.PDF
QuebecBiologics and BiosimilarsAdalimumabHadlima®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00068763.PDF
QuebecBiologics and BiosimilarsAdalimumabHyrimoz®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073497.PDF
QuebecBiologics and BiosimilarsAdalimumabIdacio®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00058541.PDF
QuebecBiologics and BiosimilarsAdalimumabAmgevita®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00067468.PDF
QuebecBiologics and BiosimilarsAdalimumabHulio®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00071858.PDF
QuebecBiologics and BiosimilarsAdalimumabAbriladaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00068228.PDF
QuebecBiologics and BiosimilarsAdalimumabSimlandiYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075380.PDF
QuebecBiologics and BiosimilarsAdalimumabYuflymaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069429.PDF
QuebecSystemic DrugsApremilastOtezla®Yes – S/ANohttps://pdf.hres.ca/dpd_pm/00057499.PDF
QuebecBiologics and BiosimilarsBimekizumabBimzelxYes – S/ANohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
QuebecBiologics and BiosimilarsBrodalumabSiliq™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
QuebecSystemic DrugsCelecoxibCelebrexN/AYeshttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
QuebecBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – S/Ahttps://pdf.hres.ca/dpd_pm/00053920.PDF
QuebecPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
QuebecPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
QuebecPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
QuebecSystemic DrugsCyclosporineYesN/A
QuebecBiologics and BiosimilarsEtanerceptEnbrel®Yes – S/A. If treatment began before August 19, 2020 Yes – S/A. If treatment began before August 19, 2020 https://pdf.hres.ca/dpd_pm/00060454.PDF
QuebecBiologics and BiosimilarsEtanerceptErelzi™Yes – S/AYes – S/A https://pdf.hres.ca/dpd_pm/00069556.PDF
QuebecBiologics and BiosimilarsEtanerceptBrenzys®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00065129.PDF
QuebecBiologics and BiosimilarsEtanerceptRymtiYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00068678.PDF27 Jun, 2024
QuebecBiologics and BiosimilarsGolimumabSimponi®N/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00074084.PDF
QuebecBiologics and BiosimilarsGuselkumabTremfya®Yes - S/ANohttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
QuebecPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®Yes - S/AN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF27 Jun, 2024
QuebecBiologics and BiosimilarsInfliximabRemicade®Yes – S/A. If treatment began before August 19, 2020 Yes – S/A. If treatment began before August 19, 2020 https://pdf.hres.ca/dpd_pm/00075118.PDF
QuebecBiologics and BiosimilarsInfliximabAvsola®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00065940.PDF
QuebecBiologics and BiosimilarsInfliximabInflectra®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00057004.PDF
SaskatchewanBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
SaskatchewanSystemic DrugsAcitretinSoriatane®Yes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
SaskatchewanBiologics and BiosimilarsAdalimumabHumira®NoNohttps://pdf.hres.ca/dpd_pm/00067414.PDF27 Jun, 2024
SaskatchewanBiologics and BiosimilarsAdalimumabHadlima®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00068763.PDF
SaskatchewanBiologics and BiosimilarsAdalimumabHyrimoz®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00073497.PDF
SaskatchewanBiologics and BiosimilarsAdalimumabIdacio®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00058541.PDF
SaskatchewanBiologics and BiosimilarsAdalimumabAmgevita®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00067468.PDF
SaskatchewanBiologics and BiosimilarsAdalimumabHulio®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00071858.PDF
SaskatchewanBiologics and BiosimilarsAdalimumabAbriladaYes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
SaskatchewanBiologics and BiosimilarsAdalimumabSimlandiYes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00075380.PDF27 Jun, 2024
SaskatchewanBiologics and BiosimilarsAdalimumabYuflymaYes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00069429.PDF27 Jun, 2024
SaskatchewanSystemic DrugsApremilastOtezla®NoNohttps://pdf.hres.ca/dpd_pm/00057499.PDF
SaskatchewanBiologics and BiosimilarsBimekizumabBimzelxYes - EDSNohttps://pdf.hres.ca/dpd_pm/00074908.PDF27 Jun, 2024
SaskatchewanBiologics and BiosimilarsBrodalumabSiliq™Yes – EDSNohttps://pdf.hres.ca/dpd_pm/00075300.PDF
SaskatchewanSystemic DrugsCelecoxibCelebrexYesYeshttps://pdf.hres.ca/dpd_pm/00041466.PDF27 Jun, 2024
SaskatchewanBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – EDShttps://pdf.hres.ca/dpd_pm/00053920.PDF
SaskatchewanPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
SaskatchewanPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYesN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
SaskatchewanPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
SaskatchewanSystemic DrugsCyclosporineYes – EDSN/A
SaskatchewanBiologics and BiosimilarsEtanerceptEnbrel®NoNohttps://pdf.hres.ca/dpd_pm/00060454.PDF27 Jun, 2024
SaskatchewanBiologics and BiosimilarsEtanerceptErelzi™Yes – EDS Yes – EDShttps://pdf.hres.ca/dpd_pm/00069556.PDF
SaskatchewanBiologics and BiosimilarsEtanerceptBrenzys®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00065129.PDF
SaskatchewanBiologics and BiosimilarsGolimumabSimponi®NoYes – EDShttps://pdf.hres.ca/dpd_pm/00074084.PDF
SaskatchewanBiologics and BiosimilarsGuselkumabTremfya®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00075605.PDF27 Jun, 2024
SaskatchewanPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®YesN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF27 Jun, 2024
SaskatchewanBiologics and BiosimilarsInfliximabRemicade®NoNohttps://pdf.hres.ca/dpd_pm/00075118.PDF27 Jun, 2024
SaskatchewanBiologics and BiosimilarsInfliximabAvsola®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00065940.PDF
SaskatchewanBiologics and BiosimilarsInfliximabInflectra®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00057004.PDF
YukonBiologics and BiosimilarsAbataceptOrencia®NoNohttps://pdf.hres.ca/dpd_pm/00070861.PDF
YukonSystemic DrugsAcitretinSoriatane®Yes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
YukonBiologics and BiosimilarsAdalimumabHumira®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00067414.PDF
YukonBiologics and BiosimilarsAdalimumabHadlima®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00068763.PDF27 Jun, 2024
YukonBiologics and BiosimilarsAdalimumabHyrimoz®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00073497.PDF27 Jun, 2024
YukonBiologics and BiosimilarsAdalimumabIdacio®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00058541.PDF27 Jun, 2024
YukonBiologics and BiosimilarsAdalimumabAmgevita®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00067468.PDF27 Jun, 2024
YukonBiologics and BiosimilarsAdalimumabHulio®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00071858.PDF27 Jun, 2024
YukonBiologics and BiosimilarsAdalimumabAbriladaYes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00068228.PDF27 Jun, 2024
YukonBiologics and BiosimilarsAdalimumabSimlandiYes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00075380.PDF27 Jun, 2024
YukonBiologics and BiosimilarsAdalimumabYuflymaYes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00069429.PDF27 Jun, 2024
YukonSystemic DrugsApremilastOtezla®NoNohttps://pdf.hres.ca/dpd_pm/00057499.PDF
YukonBiologics and BiosimilarsBimekizumabBimzelxNoNohttps://pdf.hres.ca/dpd_pm/00074908.PDF
YukonBiologics and BiosimilarsBrodalumabSiliq™NoN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
YukonSystemic DrugsCelecoxibN/AYes
YukonBiologics and BiosimilarsCertolizumab pegolCimzia®NoYes – EDShttps://pdf.hres.ca/dpd_pm/00053920.PDF
YukonPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_GelYesN/Ahttps://pdf.hres.ca/dpd_pm/00055197.PDF
YukonPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsDovobet®_OintmentYesN/Ahttps://pdf.hres.ca/dpd_pm/00034364.PDF
YukonPrescription Topical TreatmentsCombination Vitamin D3 Analogues and CorticosteroidsEnstilar™_FoamYesN/Ahttps://pdf.hres.ca/dpd_pm/00065877.PDF
YukonSystemic DrugsCyclosporineYesN/A
YukonBiologics and BiosimilarsEtanerceptEnbrel®Yes - EDS ; all new etanercept patients will be covered for Brenzys or ErelziYes – EDS; all new etanercept patients will be covered for Erelzi https://pdf.hres.ca/dpd_pm/00060454.PDF
YukonBiologics and BiosimilarsEtanerceptErelzi™Yes - EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00069556.PDF27 Jun, 2024
YukonBiologics and BiosimilarsEtanerceptBrenzys®Yes - EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00065129.PDF27 Jun, 2024
YukonBiologics and BiosimilarsGolimumabSimponi®N/AYes – EDShttps://pdf.hres.ca/dpd_pm/00074084.PDF
YukonBiologics and BiosimilarsGuselkumabTremfya®NoNohttps://pdf.hres.ca/dpd_pm/00075605.PDF
YukonPrescription Topical TreatmentsHalobetasol propionate and tazaroteneDUOBRII®NoN/Ahttps://pdf.hres.ca/dpd_pm/00066402.PDF
YukonBiologics and BiosimilarsInfliximabRemicade®Yes – EDS; all new infliximab patients will be covered for Inflectra brand only.Yes – EDS; all new infliximab patients will be covered for Inflectra brand only.https://pdf.hres.ca/dpd_pm/00075118.PDF
YukonBiologics and BiosimilarsInfliximabAvsola®NoNohttps://pdf.hres.ca/dpd_pm/00065940.PDF
YukonBiologics and BiosimilarsInfliximabInflectra®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00057004.PDF
AlbertaBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
AlbertaBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDFNov 14, 2022
AlbertaBiologics and BiosimilarsInfliximabRenflexis®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00072737.PDF
AlbertaBiologics and BiosimilarsIxekizumabTaltz®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069828.PDF
AlbertaSystemic DrugsLeflunomideArava®NoNohttps://pdf.hres.ca/dpd_pm/00067731.PDF27 Jun, 2024
AlbertaSystemic DrugsMethotrexateYesYeshttps://pdf.hres.ca/dpd_pm/00075159.PDF
AlbertaBiologics and BiosimilarsRisankizumabSkyrizi™Yes – S/AN/A
British ColumbiaBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF27 Jun, 2024
British ColumbiaBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF27 Jun, 2024
British ColumbiaBiologics and BiosimilarsInfliximabRenflexis®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00072737.PDF
British ColumbiaBiologics and BiosimilarsIxekizumabTaltz®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069828.PDF
British ColumbiaSystemic DrugsLeflunomideArava®YesYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
British ColumbiaSystemic DrugsMethotrexateYesYes
British ColumbiaBiologics and BiosimilarsRisankizumabSkyrizi™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
ManitobaBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
ManitobaBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
ManitobaBiologics and BiosimilarsInfliximabRenflexis®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00072737.PDF
ManitobaBiologics and BiosimilarsIxekizumabTaltz®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00069828.PDF
ManitobaBiologics and BiosimilarsIxekizumabSiliq™Yes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
ManitobaSystemic DrugsLeflunomideArava®NoNohttps://pdf.hres.ca/dpd_pm/00067731.PDF
ManitobaBiologics and BiosimilarsRisankizumabSkyrizi™Yes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
New BrunswickBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
New BrunswickBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
New BrunswickBiologics and BiosimilarsInfliximabRenflexis®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00072737.PDF
New BrunswickBiologics and BiosimilarsIxekizumabTaltz®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069828.PDF
New BrunswickSystemic DrugsLeflunomideArava®N/AYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
New BrunswickSystemic DrugsMethotrexateYesYes
New BrunswickBiologics and BiosimilarsRisankizumabSkyrizi™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
Newfoundland and LabradorBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
Newfoundland and LabradorBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
Newfoundland and LabradorBiologics and BiosimilarsInfliximabRenflexis®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00072737.PDF
Newfoundland and LabradorBiologics and BiosimilarsIxekizumabTaltz®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069828.PDF
Newfoundland and LabradorSystemic DrugsLeflunomideArava®N/AYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
Newfoundland and LabradorSystemic DrugsMethotrexateYesYes
Newfoundland and LabradorBiologics and BiosimilarsRisankizumabSkyrizi™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
NIHBBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
NIHBBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
NIHBBiologics and BiosimilarsInfliximabRenflexis®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00072737.PDF
NIHBBiologics and BiosimilarsIxekizumabTaltz®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00069828.PDF
NIHBSystemic DrugsLeflunomideArava®YesYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
NIHBSystemic DrugsMethotrexateYesYes
NIHBBiologics and BiosimilarsRisankizumabSkyrizi™Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
Northwest TerritoriesBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
Northwest TerritoriesBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
Northwest TerritoriesBiologics and BiosimilarsInfliximabRenflexis®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00072737.PDF
Northwest TerritoriesBiologics and BiosimilarsIxekizumabTaltz®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00069828.PDF
Northwest TerritoriesSystemic DrugsLeflunomideArava®N/AYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
Northwest TerritoriesSystemic DrugsMethotrexateYesYes
Northwest TerritoriesBiologics and BiosimilarsRisankizumabSkyrizi™Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
Nova ScotiaBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
Nova ScotiaBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
Nova ScotiaBiologics and BiosimilarsInfliximabRenflexis®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00072737.PDF
Nova ScotiaBiologics and BiosimilarsIxekizumabTaltz®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00069828.PDF
Nova ScotiaSystemic DrugsLeflunomideArava®N/AYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
Nova ScotiaSystemic DrugsMethotrexateYesYes
Nova ScotiaBiologics and BiosimilarsRisankizumabSkyrizi™Yes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
NunavutSystemic DrugsUpadacitinibRinvoq®N/ANohttps://pdf.hres.ca/dpd_pm/00073108.PDF
NunavutBiologics and BiosimilarsEtanerceptRymtiNoYes - L/Uhttps://pdf.hres.ca/dpd_pm/00068678.PDF27 Jun, 2024
NunavutBiologics and BiosimilarsBrodalumabSiliq™Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00075300.PDF
NunavutBiologics and BiosimilarsAdalimumabSimlandiYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00075380.PDF
NunavutBiologics and BiosimilarsGolimumabSimponi®N/AYes – L/Uhttps://pdf.hres.ca/dpd_pm/00074084.PDF
NunavutBiologics and BiosimilarsRisankizumabSkyrizi™Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
NunavutSystemic DrugsAcitretinSoriatane®YesN/Ahttps://pdf.hres.ca/dpd_pm/00046848.PDF
OntarioBiologics and BiosimilarsInfliximabRemicade®Yes - EAPYes - EAPhttps://pdf.hres.ca/dpd_pm/00075118.PDF
OntarioBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
OntarioBiologics and BiosimilarsInfliximabRenflexis®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00072737.PDF
OntarioBiologics and BiosimilarsIxekizumabTaltz®Yes – L/UYes - EAPhttps://pdf.hres.ca/dpd_pm/00069828.PDF
OntarioSystemic DrugsLeflunomideArava®YesYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
OntarioSystemic DrugsMethotrexateYesYes
OntarioBiologics and BiosimilarsRisankizumabSkyrizi™Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
Prince Edward IslandBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
Prince Edward IslandBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
Prince Edward IslandBiologics and BiosimilarsInfliximabRenflexis®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00072737.PDF
Prince Edward IslandBiologics and BiosimilarsIxekizumabTaltz®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069828.PDF
Prince Edward IslandSystemic DrugsLeflunomideArava®N/AYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
Prince Edward IslandSystemic DrugsMethotrexateYesYes
Prince Edward IslandBiologics and BiosimilarsRisankizumabSkyrizi™Yes – S/A N/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
QuebecBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
QuebecBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
QuebecBiologics and BiosimilarsInfliximabRenflexis®Yes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00072737.PDF
QuebecBiologics and BiosimilarsIxekizumabTaltz®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00069828.PDF
QuebecSystemic DrugsLeflunomideArava®N/AYeshttps://pdf.hres.ca/dpd_pm/00067731.PDF
QuebecSystemic DrugsMethotrexateYesYes
QuebecBiologics and BiosimilarsRisankizumabSkyrizi™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
SaskatchewanBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
SaskatchewanBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
SaskatchewanBiologics and BiosimilarsInfliximabRenflexis®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00072737.PDF
SaskatchewanBiologics and BiosimilarsIxekizumabTaltz®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00069828.PDF
SaskatchewanSystemic DrugsLeflunomideArava®NoYes – EDShttps://pdf.hres.ca/dpd_pm/00067731.PDF
SaskatchewanSystemic DrugsMethotrexateYesYes
SaskatchewanBiologics and BiosimilarsRisankizumabSkyrizi™Yes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
YukonBiologics and BiosimilarsInfliximabOmvyence™NoNohttps://pdf.hres.ca/dpd_pm/00068865.PDF
YukonBiologics and BiosimilarsInfliximabRemsima™NoNohttps://pdf.hres.ca/dpd_pm/00074581.PDF
YukonBiologics and BiosimilarsInfliximabRenflexis®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00072737.PDF
YukonBiologics and BiosimilarsIxekizumabTaltz®Yes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00069828.PDF
YukonSystemic DrugsLeflunomideArava®NoNohttps://pdf.hres.ca/dpd_pm/00067731.PDF
YukonSystemic DrugsMethotrexateYesYes
YukonBiologics and BiosimilarsRisankizumabSkyrizi™Yes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00075159.PDF
AlbertaBiologics and BiosimilarsSecukinumabCosentyx®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075631.PDF
AlbertaSystemic DrugsSulfasalazineYesYes
AlbertaBiologics and BiosimilarsTildrakizumabIlumya™Yes - SAN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
AlbertaSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
AlbertaPrescription Topical TreatmentsTopical RetinoidsTazaroteneYesN/ANo information available
AlbertaSystemic DrugsUpadacitinibRinvoq®N/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073108.PDF
AlbertaBiologics and BiosimilarsUstekinumabStelara®Yes – S/ANohttps://pdf.hres.ca/dpd_pm/00073994.PDF
AlbertaBiologics and BiosimilarsUstekinumabWezlanaYes – S/ANohttps://pdf.hres.ca/dpd_pm/00073953.PDF27 Jun, 2024
AlbertaBiologics and BiosimilarsUstekinumabJamtekiYes – S/ANohttps://pdf.hres.ca/dpd_pm/00073286.PDF27 Jun, 2024
AlbertaPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
AlbertaPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®NoN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
British ColumbiaBiologics and BiosimilarsSecukinumabCosentyx®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075631.PDF
British ColumbiaSystemic DrugsSulfasalazineSalazopyrinYesYes
British ColumbiaBiologics and BiosimilarsTildrakizumabIlumya™NoN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
British ColumbiaSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
British ColumbiaPrescription Topical TreatmentsTopical RetinoidsTazaroteneYesN/ANo information available
British ColumbiaSystemic DrugsUpadacitinibRinvoq®N/ANohttps://pdf.hres.ca/dpd_pm/00073108.PDF
British ColumbiaBiologics and BiosimilarsUstekinumabStelara®Yes – S/A until Dec 3 2024Nohttps://pdf.hres.ca/dpd_pm/00073994.PDF
British ColumbiaBiologics and BiosimilarsUstekinumabJamtekiYes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00073286.PDF27 Jun, 2024
British ColumbiaPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
British ColumbiaPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®NoN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
ManitobaBiologics and BiosimilarsSecukinumabCosentyx®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00075631.PDF
ManitobaSystemic DrugsSulfasalazinepms-Sulfasalazine, SalazopyrinYesYes
ManitobaBiologics and BiosimilarsTildrakizumabIlumya™Yes - EDSN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
ManitobaSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
ManitobaPrescription Topical TreatmentsTopical RetinoidsTazaroteneNoN/ANo information available
ManitobaSystemic DrugsUpadacitinibRinvoq®N/AYes - EDShttps://pdf.hres.ca/dpd_pm/00073108.PDF
ManitobaBiologics and BiosimilarsUstekinumabStelara®Yes – EDSNohttps://pdf.hres.ca/dpd_pm/00073994.PDF
ManitobaPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
ManitobaPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®NoN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
New BrunswickBiologics and BiosimilarsSecukinumabCosentyx®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075631.PDF
New BrunswickSystemic DrugsSulfasalazineSalazopyrinN/AYes
New BrunswickBiologics and BiosimilarsTildrakizumabIlumya™Yes - SAN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
New BrunswickSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
New BrunswickPrescription Topical TreatmentsTopical RetinoidsTazaroteneYes – S/AN/A
New BrunswickSystemic DrugsUpadacitinibRinvoq®N/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073108.PDF
New BrunswickBiologics and BiosimilarsUstekinumabStelara®NoNohttps://pdf.hres.ca/dpd_pm/00073994.PDF
New BrunswickBiologics and BiosimilarsUstekinumabJamtekiYes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00073286.PDF27 Jun, 2024
New BrunswickBiologics and BiosimilarsUstekinumabWezlanaYes - S/AYes - S/Ahttps://pdf.hres.ca/dpd_pm/00073953.PDF27 Jun, 2024
New BrunswickPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
New BrunswickPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®YesN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
Newfoundland and LabradorBiologics and BiosimilarsSecukinumabCosentyx®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075631.PDF
Newfoundland and LabradorSystemic DrugsSulfasalazineN/AYes
Newfoundland and LabradorBiologics and BiosimilarsTildrakizumabIlumya™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
Newfoundland and LabradorSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
Newfoundland and LabradorPrescription Topical TreatmentsTopical RetinoidsTazaroteneNoN/ANo information available
Newfoundland and LabradorSystemic DrugsUpadacitinibRinvoq®N/AYes – S/A https://pdf.hres.ca/dpd_pm/00073108.PDF
Newfoundland and LabradorBiologics and BiosimilarsUstekinumabStelara®Yes – S/ANohttps://pdf.hres.ca/dpd_pm/00073994.PDF
Newfoundland and LabradorBiologics and BiosimilarsUstekinumabJamtekiYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073286.PDF27 Jun, 2024
Newfoundland and LabradorBiologics and BiosimilarsUstekinumabWezlanaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073953.PDF27 Jun, 2024
Newfoundland and LabradorPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
Newfoundland and LabradorPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®NoN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
NIHBBiologics and BiosimilarsSecukinumabCosentyx®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00075631.PDF
NIHBSystemic DrugsSulfasalazineYesYes
NIHBBiologics and BiosimilarsTildrakizumabIlumya™Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
NIHBSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
NIHBPrescription Topical TreatmentsTopical RetinoidsTazaroteneYesN/ANo information available
NIHBSystemic DrugsUpadacitinibRinvoq®N/AYes- L/Uhttps://pdf.hres.ca/dpd_pm/00073108.PDF
NIHBBiologics and BiosimilarsUstekinumabStelara®Yes – L/UNohttps://pdf.hres.ca/dpd_pm/00073994.PDF
NIHBBiologics and BiosimilarsUstekinumabWezlanaYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00073953.PDF27 Jun, 2024
NIHBPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
NIHBPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®NoN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
Northwest TerritoriesBiologics and BiosimilarsSecukinumabCosentyx®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00075631.PDF
Northwest TerritoriesSystemic DrugsSulfasalazineN/AYes
Northwest TerritoriesBiologics and BiosimilarsTildrakizumabIlumya™NoN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
Northwest TerritoriesSystemic DrugsTofacitinibXeljanz®NoNohttps://pdf.hres.ca/dpd_pm/00075206.PDF
Northwest TerritoriesPrescription Topical TreatmentsTopical RetinoidsTazaroteneYesN/ANo information available
Northwest TerritoriesSystemic DrugsUpadacitinibRinvoq®N/ANohttps://pdf.hres.ca/dpd_pm/00073108.PDF
Northwest TerritoriesBiologics and BiosimilarsUstekinumabStelara®Yes – L/UNohttps://pdf.hres.ca/dpd_pm/00073994.PDF
Northwest TerritoriesBiologics and BiosimilarsUstekinumabWezlanaYes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00073953.PDF27 Jun, 2024
Northwest TerritoriesPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
Northwest TerritoriesPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®NoN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
Nova ScotiaBiologics and BiosimilarsSecukinumabCosentyx®Yes – EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00075631.PDF
Nova ScotiaSystemic DrugsSulfasalazineN/AYes
Nova ScotiaBiologics and BiosimilarsTildrakizumabIlumya™Yes – EDSN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
Nova ScotiaSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
Nova ScotiaPrescription Topical TreatmentsTopical RetinoidsTazaroteneYes – EDSN/ANo information available
Nova ScotiaSystemic DrugsUpadacitinibRinvoq®N/AYes – EDShttps://pdf.hres.ca/dpd_pm/00073108.PDF
Nova ScotiaBiologics and BiosimilarsUstekinumabStelara®Yes - EDSNohttps://pdf.hres.ca/dpd_pm/00073994.PDF
Nova ScotiaBiologics and BiosimilarsUstekinumabJamtekiYes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00073286.PDF
Nova ScotiaBiologics and BiosimilarsUstekinumabWezlanaYes - EDSYes - EDShttps://pdf.hres.ca/dpd_pm/00073953.PDF27 Jun, 2024
Nova ScotiaPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®Yes - EDSN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
Nova ScotiaPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®YesN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
NunavutBiologics and BiosimilarsUstekinumabStelara®Yes – L/UNohttps://pdf.hres.ca/dpd_pm/00073994.PDF
NunavutBiologics and BiosimilarsIxekizumabTaltz®Yes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00069828.PDF
NunavutPrescription Topical TreatmentsTopical RetinoidsTazaroteneYesN/ANo information available
NunavutBiologics and BiosimilarsGuselkumabTremfya®Yes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00075605.PDF
NunavutBiologics and BiosimilarsUstekinumabWezlanaYes – L/UYes – L/Uhttps://pdf.hres.ca/dpd_pm/00073953.PDF27 Jun, 2024
NunavutSystemic DrugsTofacitinibXeljanz®NoNohttps://pdf.hres.ca/dpd_pm/00075206.PDF
NunavutBiologics and BiosimilarsAdalimumabYuflymaYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00069429.PDF
NunavutSystemic DrugsCyclosporineYesYes
NunavutSystemic DrugsMethotrexateYesYes
NunavutSystemic DrugsSulfasalazineN/AYes
OntarioBiologics and BiosimilarsSecukinumabCosentyx®Yes – L/UYes - EAPhttps://pdf.hres.ca/dpd_pm/00075631.PDF
OntarioSystemic DrugsSulfasalazineN/AYes
OntarioBiologics and BiosimilarsTildrakizumabIlumya™Yes - L/UN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
OntarioSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
OntarioPrescription Topical TreatmentsTopical RetinoidsTazaroteneNoN/ANo information available
OntarioSystemic DrugsUpadacitinibRinvoq®N/ANohttps://pdf.hres.ca/dpd_pm/00073108.PDF
OntarioBiologics and BiosimilarsUstekinumabStelara®Yes – L/UNohttps://pdf.hres.ca/dpd_pm/00073994.PDF
OntarioBiologics and BiosimilarsUstekinumabJamtekiYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00073286.PDF
OntarioBiologics and BiosimilarsUstekinumabWezlanaYes - L/UYes - L/Uhttps://pdf.hres.ca/dpd_pm/00073953.PDF27 Jun, 2024
OntarioPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
OntarioPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®Yes – L/UN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
Prince Edward IslandBiologics and BiosimilarsSecukinumabCosentyx®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075631.PDF
Prince Edward IslandSystemic DrugsSulfasalazineN/AYes
Prince Edward IslandBiologics and BiosimilarsTildrakizumabIlumya™Yes – S/AN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF27 Jun, 2024
Prince Edward IslandSystemic DrugsTofacitinibXeljanz®NoNohttps://pdf.hres.ca/dpd_pm/00075206.PDF
Prince Edward IslandPrescription Topical TreatmentsTopical RetinoidsTazaroteneNoN/ANo information available
Prince Edward IslandSystemic DrugsUpadacitinibRinvoq®N/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073108.PDF
Prince Edward IslandBiologics and BiosimilarsUstekinumabStelara®Yes – S/ANohttps://pdf.hres.ca/dpd_pm/00073994.PDF
Prince Edward IslandPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
Prince Edward IslandPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®NoN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
QuebecBiologics and BiosimilarsSecukinumabCosentyx®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00075631.PDF
QuebecSystemic DrugsSulfasalazineN/AYes
QuebecBiologics and BiosimilarsTildrakizumabIlumya™NoN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
QuebecSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
QuebecPrescription Topical TreatmentsTopical RetinoidsTazaroteneNoN/ANo information available
QuebecSystemic DrugsUpadacitinibRinvoq®N/AYes – S/A https://pdf.hres.ca/dpd_pm/00073108.PDF
QuebecBiologics and BiosimilarsUstekinumabStelara®Yes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073994.PDF
QuebecBiologics and BiosimilarsUstekinumabJamtekiYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073286.PDF
QuebecBiologics and BiosimilarsUstekinumabWezlanaYes – S/AYes – S/Ahttps://pdf.hres.ca/dpd_pm/00073953.PDF27 Jun, 2024
QuebecPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
QuebecPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®YesN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
SaskatchewanBiologics and BiosimilarsSecukinumabCosentyx®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00075631.PDF
SaskatchewanSystemic DrugsSulfasalazineN/AYes
SaskatchewanBiologics and BiosimilarsTildrakizumabIlumya™Yes - EDSN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
SaskatchewanSystemic DrugsTofacitinibXeljanz®N/ANohttps://pdf.hres.ca/dpd_pm/00075206.PDF
SaskatchewanPrescription Topical TreatmentsTopical RetinoidsTazaroteneYesN/ANo information available
SaskatchewanSystemic DrugsUpadacitinibRinvoq®N/AYes – EDShttps://pdf.hres.ca/dpd_pm/00073108.PDF
SaskatchewanBiologics and BiosimilarsUstekinumabStelara®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00073994.PDF
SaskatchewanPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
SaskatchewanPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®NoN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF
YukonBiologics and BiosimilarsSecukinumabCosentyx®Yes – EDSYes – EDShttps://pdf.hres.ca/dpd_pm/00075631.PDF
YukonSystemic DrugsSulfasalazineN/AYes
YukonBiologics and BiosimilarsTildrakizumabIlumya™NoN/Ahttps://pdf.hres.ca/dpd_pm/00064464.PDF
YukonSystemic DrugsTofacitinibXeljanz®NoNohttps://pdf.hres.ca/dpd_pm/00075206.PDF
YukonPrescription Topical TreatmentsTopical RetinoidsTazaroteneYesN/ANo information available
YukonSystemic DrugsUpadacitinibRinvoq®N/ANohttps://pdf.hres.ca/dpd_pm/00073108.PDF
YukonBiologics and BiosimilarsUstekinumabStelara®Yes – EDSNohttps://pdf.hres.ca/dpd_pm/00073994.PDF
YukonPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcipotriol - Dovonex®YesN/Ahttps://pdf.hres.ca/dpd_pm/00064010.PDF
YukonPrescription Topical TreatmentsVitamin_D3_Analogues(Dovonex® Silkis®)Calcitriol - Silkis®YesN/Ahttps://pdf.hres.ca/dpd_pm/00041695.PDF

More information is available on S/A (special access), L/U (limited use) and Exceptional Drug Status (EDS) at Special Access / Limited Use Designation Drugs.

NIHB stands for non-insured health benefits.

This site is updated regularly; however this information is subject to change. Access may also vary depending on the specific plan. For the most up-to-date information regarding your specific province / territory click here.